Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling.

Am J Respir Crit Care Med

Division of Pulmonary Sciences and Critical Care Medicine, Cardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262, USA.

Published: July 2001

Prostacyclin (PGI(2)) reduces pulmonary vascular resistance and attenuates vascular smooth muscle cell proliferation through signal transduction following ligand binding to its receptor. Because patients with severe pulmonary hypertension have a reduced PGI(2) receptor (PGI-R) expression in the remodeled pulmonary arterial smooth muscle, we hypothesized that pulmonary vascular remodeling may be modified PGI-R dependently. To test this hypothesis, PGI-R knockout (KO) and wild-type (WT) mice were subjected to a simulated altitude of 17,000 ft or Denver altitude for 3 wk, and right ventricular pressure and lung histology were assessed. The PGI-R KO mice developed more severe pulmonary hypertension and vascular remodeling after chronic hypoxic exposure when compared to the WT mice. Our results indicate that PGI(2) and its receptor play an important role in the regulation of hypoxia-induced pulmonary vascular remodeling, and that the absence of a functional receptor worsens pulmonary hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.1164/ajrccm.164.2.2010150DOI Listing

Publication Analysis

Top Keywords

pulmonary vascular
16
vascular remodeling
16
pulmonary hypertension
12
pulmonary
8
smooth muscle
8
severe pulmonary
8
pgi2 receptor
8
vascular
6
prostacyclin receptor-dependent
4
receptor-dependent modulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!